ICU Medical (icui) Strengthens Amid Competitors’ Quality Issues

In its first-quarter 2026 investor letter, Madison Small Cap Fund Strategy highlighted ICU Medical, Inc. (NASDAQ:ICUI) as a newly added position. ICU Medical, Inc. (NASDAQ:ICUI) is a leading medical device company specializing in the development of products used in infusio

In its first-quarter 2026 investor letter, Madison Small Cap Fund Strategy highlighted ICU Medical, Inc. (NASDAQ:ICUI) as a newly added position.

ICU Medical, Inc. (NASDAQ:ICUI) is a leading medical device company specializing in the development of products used in infusion therapy, vascular access, and vital care applications

On June 11, 2026, ICU Medical, Inc. (NASDAQ:ICUI) closed at $142.86 per share. One-month return of ICU Medical, Inc. (NASDAQ:ICUI) was 20.33%, and its shares gained 8.19% over the past 52 weeks. ICU Medical, Inc. (NASDAQ:ICUI) has a market capitalization of $3.57 billion.

Madison Small Cap Fund stated the following regarding ICU Medical, Inc. (NASDAQ:ICUI) in its Q1 2026 investor letter: “ICU Medical, Inc. (NASDAQ:ICUI) is a medical device company that specializes in infusion therapy, vascular access, and vital care applications. The company’s main business is intravenous delivery devices, and it provides both systems and consumables associated with these pumps. The business is headquartered in San Clemente, California, and has been around for over 40 years.

Leave a Reply

Your email address will not be published. Required fields are marked *